Citeline Regulatory’s Post

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/ITpu50Sm11S In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/L9Jp50SiuBf In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

In this podcast, Kerrie Brady, OcuTerra Therapeutics, and Susan Nemetz, The NemetzGroup LLC, Corval, use their experience to identify the value of commercialization plans for listeners. More specifically, they discuss: • How those plans can translate into acquisition value • When to put resources into commercial and medical affairs teams • What are the first steps they would recommend taking that lead to maximum impact Listen to the full interview here: https://lnkd.in/e67ysreJ #DPHARM #clinicalresearch #clinicaltrials

🔍 Discover how Alisa joined the world of biologics, which is very different from her experiences in emergency management. In Episode 26 of That's Derm Good!, Alisa Redmon explains how treatments impact your patients' lives and the satisfaction of visually seeing changes in your patients skin. Listen wherever you find your favorite podcasts!

Strong recommendation to listen to Acquired's episode on Novo Nordisk and the GLP-1 drug class. Beyond covering the obvious topics of the company (fascinating structure and history) and the drug class (fascinating impact) the episode steps into some of the wonkiness of how the pharma value chain currently functions and how we got here. They don't approach the topic from a healthcare first mindset, rather from an investor POV, which I think allows them to be fairly even-handed in doling out observational criticism and support for the various players. ⭐ Mostly, I think the podcast series is a fantastic reminder that every company, every person, every trend has a story. In running TEND, I'm striving to keep that front and center each day as we partner in leading remarkable executive search processes for healthcare investors and leadership teams. If you listen, share your thoughts below... Another episode worth listening to is on Costco Wholesale. Thanks Ethan Ott for originally pointing me toward the podcast!

Achieving consistent production of biological therapeutics presents distinctive challenges in bioanalysis. Find out how we addressed these challenges and ensured superior sensitivity in this poster presentation. #DrugDevelopment #Biologics #LifeSciences

In this complimentary webinar, you will learn more about practical considerations for the successful conduct of first-in-human Phase I studies for biologics, where collaboration between bioanalytical experts and clinical trial sites is crucial. Watch to see how you can overcome challenges throughout all phases of drug development. #DrugDevelopment #Biologics #LifeSciences

In this on-demand complimentary webinar, discover how the Sinclair Nanopig can be a relevant non-rodent model for your toxicology and pharmacology studies due to its size. Watch now: https://lnkd.in/geJ-M89m #Nonclinical #Preclinical #Toxicology

Chief Medical Officers from biotech companies Xalud Therapeutics, Inc., SparingVision, Altimmune, Inc.and Zai Lab joined us at the CMO Summit 360º in April to explain how they pitch to different investors and how their pitching methodology has evolved over time. Learn more valuable insights and lessons through this podcast. Listen to the podcast here: https://lnkd.in/gPNs6FmM #CMO #CMO360

Big Pharma vs biotech? CRO vs. consulting? My colleague and friend Nathan Teuscher shares his experiences working in different companies in life sciences in a recent episode of his podcast. Pros, cons, and all the in between. Give it a listen. ⬇️ (Oh, and you don't have to be a Clinical Pharmacologist to enjoy it. It's a good listen for anyone wondering what it's like in a different area of the industry.)